The altered gating of the mutant CFTR chloride channel cystic fibrosis (CF) may be corrected by small molecules called potentiators. We present a molecular scale simulation system for the discovery of ΔF508-CFTR soluble potentiators. Results report the design, ADME-Tox prediction, synthesis, solubility determination and in vitro biological evaluation of two 1,4-dihydropyridines (DHPs). Compound 1 shows a promising ADME–Tox profile and good potency.
Ligand-based design, in silico ADME-Tox filtering, synthesis and biological evaluation to discover new soluble 1,4-DHP-based CFTR activators
VISENTIN, Sonia;ERMONDI, Giuseppe;MEDANA, Claudio;CARON, Giulia
2012-01-01
Abstract
The altered gating of the mutant CFTR chloride channel cystic fibrosis (CF) may be corrected by small molecules called potentiators. We present a molecular scale simulation system for the discovery of ΔF508-CFTR soluble potentiators. Results report the design, ADME-Tox prediction, synthesis, solubility determination and in vitro biological evaluation of two 1,4-dihydropyridines (DHPs). Compound 1 shows a promising ADME–Tox profile and good potency.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
EJMC2012_CFTR_ejmc_manuscript_revised2.pdf
Open Access dal 24/07/2014
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
991.01 kB
Formato
Adobe PDF
|
991.01 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
